NewsRx

Search our medical news database

Gene Therapy Weekly

Susan Hasty, Publisher

Table of Contents . . . July 1st, 2004

Non-Subscriber - Summaries Only

Related Areas: Other Issues in Gene Therapy Weekly | Other Publications

Drug Resistance - Downregulated Bcl-2 or xIAP enhances the efficacy of breast cancer chemotherapy

Gastroenterology - Aurora-2 is a potential target for the treatment of pancreatic cancer

Genetic Engineering - Administration route shapes the effects of IL-12-expressing dendritic cells

Geriatrics - Plasmid-based hormone therapy could improve disease or age-induced wasting

Vector Development - Folate receptors ensure correct delivery of tumor-selective gene therapy

Awards - Doctor named young investigator of the year by gene therapy society

Bacteria - Viral Antigens enters strategic collaboration

Biotechnology - Experts warn that gene research could be used for warfare

Blood Vessel - Company announces new intravenous gene-delivery method

Breast Cancer - Survivin, Bcl-2, p53 and bax expression increased in breast carcinoma

Business Update - Company begins operation of 2500-liter bioreactor

Cancer Therapy - ADVEXIN and INGN 241 featured at international scientific conference

Cancer Therapy - Endothelial cell-specific human antibodies might retard tumor growth

Cancer Therapy - Gene therapy tested to protect bone marrow during chemotherapy

Carcinoma - Bcl-2 expression decreases in endometrial carcinomas

Collaborations - Company begins exploratory collaboration with Novartis Institutes

Colorectal Cancer - Alternative genetic pathway to human colorectal cancer found

Colorectal Cancer - Cytochrome C depletion intensifies the immunogenicity of colon cancer cells

DNA Manufacturing - Company announces DNA fermentation breakthrough

Endocrinology - Hypothalamic glutamate decarboxylase expression cuts rodent feeding behavior

Gene Therapy - New research on the progress of gene therapy presented at meeting

Gene Transfer - A new quantitative method measures the magnitude and volume of transgenes

Gene Transfer - NK4 transfection generates several modes of antitumor activity

Genetics - Company adds cell-based knockins to its vector application services

Genetics - Human Genome Project looks beyond man

Genomics - Pharmacogenomic profiling of PI3K/PTEN-AKT-mTOR pathway in tumors elucidated

Geriatrics - New research hints at genetic changes in brains that could explain aging

Growth-Hormone Deficiency - Companies agree to discontinue commercialization of Nutropin Depot

Gynecology - Bikunin plus paclitaxel trims tumor burden and ascites in ovarian cancer models

HIV/AIDS - RNAi is gene-specific therapeutic option to control HIV-1 replication

HIV/AIDS Genetics - Mutations at position 184 of HIV-1 RT affect virus titer and viral DNA synthesis

HIV/AIDS Research - Major 5' site mutation renders CMV-driven HIV-1 proviral clone Tat-dependent

HIV/AIDS Treatment - Vif-resistant mutant APOBEC3G may provide gene therapy approach to HIV infection

Hemophilia - Foundation says it's not deterred by Avigen gene-transfer therapy announcement

Hepatitis C Vaccine - Vaccine encoding hepatitis C antigens elicits specific immune response

Immunology - Cell-line company adds Dr. Stephen Chang to scientific advisory board

Immunology - Dendritic cells made to overexpress CCL21 stimulate tumor immunity

Immunology - Long-term effects seen after exposure to TCDD contamination

Immunology - NIH awards phase II SBIR to develop zebrafish apoptosis drug-screening assays

Immunology - Results on electroporation-enhanced DNA vaccine delivery presented at meeting

Immunotherapy - Lorus announces European patent to protect unique tumor suppressor

Incontinence - Recombinant IGF-1 gene therapy may improve nerve structure, function recovery

Ischemic Stroke - Post-ischemic neurotrophic factor gene transfer prevents delayed neuronal death

Patents - Gene therapy may be useful in cancer treatments

Personnel - Dr. Michael Fons tapped as executive director, corporate development

Personnel - Katherine High named president of gene therapy group

Receptor Studies - Hapten receptors bear selective delivery of imaging and therapeutic agents

Restenosis - Ultrasound-augmented nucleotide transfer harnesses neointimal growth

Stem-Cell Research - BCR-ABL has distinct biological effects in primary human hematopoietic cells

Transduction - Electric field-induced molecular vibration forges DNA transfer

Tumor Suppression - Modified thrombospondin-2 cDNA transduction stops tumor growth and angiogenesis

Vector Development - Hybrid LTR retroviruses seek and transfect tumor endothelial cells

Vector Development - PLL-modified silica nanoparticles transport antisense oligonucleotides

Virology - Alternatively spliced soluble CARs inhibit coxsackievirus infection

Virology - Viral cocktails afford efficient gene transfer in animal models

Virology - pVP2 precursor C-terminal domain essential for VP2-VP3 interaction

Return to Top of Page

NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook